Posts by: Iqra Mumal

Iqra Mumal

April 12, 2018April 12, 2018

Severe Asthma Patients with Bronchiectasis at Increased Risk of Hospitalization, Other Issues, Study Finds

News

Patients with both severe asthma and bronchiectasis are at more risk of frequent hospitalization, gastroesophageal reflux disease, hypersensitivity to nonsteroidal anti-inflammatory drugs, and higher blood eosinophil counts than patients ... Read more

April 5, 2018April 5, 2018

Bronchiectasis Patients with P. Aeruginosa Show Worse Lung Function, Lower Quality of Life in Study

News

The presence of a type of bacteria called Pseudomonas aeruginosa in Chinese patients with bronchiectasis was found to be associated with worse lung function, a higher risk for all-cause mortality, ... Read more

March 22, 2018March 22, 2018

Airway Abnormality, Immunodeficiency Are Key Causes of Non-CF Bronchiectasis in Turkey, Study Finds

News

The most common causes of non-cystic fibrosis bronchiectasis in Turkish children are an airway abnormality called primary ciliary dyskinesia and a sub-par immune system, a study reports. A high frequency of ... Read more

March 8, 2018March 8, 2018

Bronchiectasis Increases COPD Patients’ Risk of Enlarged Pulmonary Artery, Study Finds

News

Bronchiectasis increases the risk that a person with chronic obstructive pulmonary disease (COPD) will develop an enlarged pulmonary artery, a study reports. The research, “Co-existence of COPD and bronchiectasis: a ... Read more

March 1, 2018March 1, 2018

Looking for Component of a Fungus Is Good Way to Detect It in Airways, Study Reports

News

Checking the lungs of COPD and bronchiectasis patients for a component of the fungus Aspergillus fumigatus is a good way to see whether they have the infection, a study reports. In ... Read more

November 21, 2017November 21, 2017

Pseudomonas aeruginosa Infection in NCFBE Patients Leads to Higher Healthcare Costs, Study Finds

News

Patients with non-cystic fibrosis bronchiectasis (NCFBE) are subjected to higher healthcare costs after being diagnosed with Pseudomonas aeruginosa infection, a new study shows. The study recommends that future research should explore methods of ... Read more

October 17, 2017October 17, 2017

Polyphor Launches Development of Inhaled Antibiotic for Respiratory Diseases

News

Polyphor, a Swiss specialty pharmaceutical company, is launching the development of an inhaled form of the investigational antibiotic murepavadin (POL7080). Murepavadin, a type of outer membrane protein targeting antibiotic ... Read more

September 21, 2017September 21, 2017

Hematologic Malignancy and Its Treatment Linked to Development of Bronchiectasis

News

Bronchiectasis was found in patients with hematologic malignancies, independent of subtype; those who have had a stem cell transplant (SCT); developed graft-vs-host disease (GVHD); or those with immunoglobulin deficiency, ... Read more

Pin It on Pinterest